文献速递精神分裂症与精神病性障碍心境障碍

精神分裂症、双相障碍与健康对照工作记忆中的序列依赖效应

Prior Trial Effects on Working Memory in Schizophrenia, Bipolar Disorder, and Healthy Control Individuals.
PubMed 文献 · JAMA Psychiatry · 2026-01-01

该病例对照研究纳入41例双相障碍、30例精神分裂症和27例健康对照,采用工作记忆任务评估序列依赖偏倚。精神分裂症组表现为显著排斥性偏倚,双相障碍组多数呈吸引性偏倚但少数呈排斥性,提示序列偏倚可能作为精准精神病学生物标志物。

要点

  • 精神分裂症患者工作记忆表现为排斥性序列偏倚,与健康对照的吸引性偏倚相反。
  • 双相障碍患者多数呈吸引性偏倚,但部分呈排斥性偏倚,存在异质性。
  • 序列偏倚可能作为区分精神病谱系病理生理的潜在生物标志物。

核心结论

  • 健康对照与精神分裂症患者的吸引性和排斥性序列偏倚存在差异。
  • 双相障碍患者中部分呈现健康对照模式,少数呈现精神分裂症模式。
  • 序列偏倚可能作为病理生理和精准精神病学的有价值生物标志物。

研究设计与样本

  • 病例对照研究,纳入符合DSM-5诊断的精神分裂症或伴精神病性症状的双相障碍患者及匹配健康对照。
  • 临床样本来自美国5个站点的门诊精神科诊所和日间项目,健康对照来自社区。
  • 采用工作记忆任务,要求记住泪滴形物体方向并在可变延迟后重现。
  • 使用简明精神病评定量表量化症状严重程度。
  • 研究于2023年9月至2025年4月进行。

主要发现

  • 共纳入双相障碍41例(51%男性,平均年龄37.02岁)、精神分裂症30例(60%男性,平均年龄37.5岁)、健康对照27例(59%男性,平均年龄39.98岁)。
  • 精神分裂症组平均偏倚指数为-1.99(95%CI,-2.74至1.23),显著大于双相障碍组的0.44(95%CI,-0.25至1.13)和健康对照组的1.82(95%CI,1.31至2.32)。
  • 双相障碍组中13/41表现吸引性偏倚,7/41表现排斥性偏倚。

关键数值与推荐

  • 主要结局指标为偏倚指数,评估当前试次反应偏向或偏离前试次靶标的方向和程度。
  • 暴露因素为诊断组别和前试次靶标方向。

临床怎么用

  • 序列依赖偏倚可能有助于区分精神分裂症与双相障碍的认知机制。
  • 该指标有望作为精准精神病学的生物标志物,辅助病理生理研究和个体化诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Healthy individuals typically show attractive serial dependence in working memory tasks, with responses biased toward recent inputs, whereas people with schizophrenia (SZ) reliably show the opposite-repulsive biases. Determining whether individuals with bipolar disorder (BD) and a history of psychosis exhibit similar or distinct serial-dependence patterns is essential for clarifying shared vs disorder-specific cognitive mechanisms across the psychosis spectrum. OBJECTIVE: To determine whether people with BD exhibit the repulsive bias seen in people with SZ or the attractive bias seen in healthy control (HC) individuals. DESIGN, SETTING, AND PARTICIPANTS: This case-control study included individuals who met DSM-5 criteria for SZ or BD with a history of psychosis, along with matched HC participants recruited across 5 US sites. Clinical samples were recruited from outpatient psychiatric clinics and day programs, and HC participants were recruited from the community. A working memory task was used in which participants remembered the orientation of a teardrop-shaped object and reproduced it using a computer mouse after a variable delay. The Brief Psychiatric Rating Scale was used to quantify symptom severity. The study was conducted from September 2023 to April 2025. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the bias index, used to evaluate the extent to which current-trial responses were biased toward or away from previous-trial targets. EXPOSURES: Diagnostic group and the orientation of the previous trial's target during a spatial working memory paradigm. RESULTS: A total of 41 participants were included in BD group (21 [51%] male; mean [SD] age, 37.02 [11.53] years), 30 in the SZ group (18 [60%] male; mean [SD] age, 37.5 [9.04] years), and 27 in the HC group (16 [59%] male; mean [SD] age, 39.98 [11.01] years). Overall bias differed across groups, with people with SZ (mean, -1.99; 95% CI, -2.74 to 1.23) demonstrating significantly greater repulsive bias than both people with BD (mean, 0.44; 95% CI, -0.25 to 1.13) and HC individuals (mean, 1.82; 95% CI, 1.31 to 2.32). Fifteen of 27 HC individuals exhibited attractive bias, with none showing repulsive bias, whereas 17 of 30 people with SZ exhibited repulsive bias, with none showing attractive bias. Attractive bias was common in people with BD (13 of 41), but some exhibited a repulsive bias (7 of 41). CONCLUSIONS AND RELEVANCE: In this case-control study, attractive and repulsive serial biases differed between HC individuals and people with SZ, with some people with BD showing the HC pattern and few showing the SZ pattern. These results suggest that serial bias may serve as a valuable biomarker for pathophysiology and precision psychiatry.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bansal S, Bae GY, Barch DM, et al. Prior Trial Effects on Working Memory in Schizophrenia, Bipolar Disorder, and Healthy Control Individuals. JAMA Psychiatry. 2026. PMID: 41984461. doi:10.1001/jamapsychiatry.2026.0196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。